Business

Despite countless injections, pharma loses due to corona | Financial

Premium

The best of De Telegraaf

AstraZeneca and Johnson & Johnson drop out

Amsterdam – Pfizer, BioNTech and Moderna that earn very well from their corona vaccines are generating quite a bit of social resistance. Yet they are virtually the only pharmaceutical companies that will benefit financially from the pandemic. The many millions invested in the development of vaccines did not always amount to anything. For example, the vaccines from Johnson & Johnson and AstraZeneca even got sidetracked despite the approval. Nevertheless, the sector as a whole has also improved to a certain extent, because thanks to corona some developments have accelerated.

Despite countless injections, pharma loses due to corona | Financial
Source link Despite countless injections, pharma loses due to corona | Financial

Back to top button